Flavonoids are naturally occurring polyphenolic compounds that have many biological properties, including antioxidative, anti-inflammatory and
neuroprotective effects. Here, we report that
amentoflavone significantly reduced cell death induced by
staurosporine,
etoposide and
sodium nitroprusside in
neuroblastoma SH-SY5Y cells. In post-natal day 7 rats, hypoxic-ischemic (H-I) brain damage induced by unilateral carotid
ligation and
hypoxia resulted in distinct features of neuronal cell death including apoptosis and
necrosis. In this model, a systemic administration of
amentoflavone (30 mg/kg) markedly reduced the H-I-induced brain tissue loss with a wide therapeutic time window up to 6 h after the onset of
hypoxia.
Amentoflavone blocked the activation of
caspase 3, characteristic of apoptosis, and the proteolytic cleavage of its substrates following H-I injury.
Amentoflavone also reduced the excitotoxic/necrotic cell death after H-I injury in vivo and after
oxygen/
glucose deprivation in mouse mixed cultures in vitro. Treatment of mouse microglial cells with
amentoflavone resulted in a significant decrease in the
lipopolysaccharide-induced production of
nitric oxide and induction of
inducible nitric oxide synthase and cyclo-oxygenase-2. Furthermore,
amentoflavone decreased the inflammatory activation of microglia after H-I injury when assessed by the microglial-specific marker OX-42. These data demonstrate for the first time that
amentoflavone strongly protects the neonatal brain from H-I injury by blocking multiple cellular events leading to brain damage.